Oral Administration: BPC-157 can be taken orally, typically as capsules or powder
People with Parkinson's People with Stroke, MS, Spinal Cord Injury, Chronic Disabilities People with chronic issues battle them long after completing rehab
DSIP DSIP (Delta SleepInducing Peptide) is a neuropeptide studied for its potential role in sleep architecture modulation and stress-response regulation
Efficacy and safety of AM-111 in the treatment of acute unilateral sudden deafness - a double-blind, randomized, placebo-controlled phase 3 study
Expected timeline: Month 1-2: Inflammation management, symptomatic improvement Month 3-6: Potential slowing of degenerative markers, quality of life improvement Month 6-12: Assessment of structural changes, protocol optimization Ongoing: Maintenance protocols as needed, cycling strategies Complementary approaches: Anti-inflammatory nutrition
Side effects are rare and usually mild, but its still helpful to know what to expect